Cerno Health

18/07/2026

18/07/2026

🌍 BREAKING MEDICAL NEWS: A game-changer for prostate cancer treatment. 🌍

A landmark 10-year study just confirmed that HIFU (High-Intensity Focused Ultrasound) provides excellent long-term cancer control while saving men from life-altering side effects.

Traditional treatments like radical surgery or full radiation are effective, but they often come with high risks of urinary incontinence or erectile dysfunction.

The new data, tracking nearly 3,500 men over a decade, shows that HIFU—which zaps only the tumour and protects healthy tissue—offers:

✅ Equivalent survival rates to major surgery and radiation.
✅ A 5x lower risk of urinary and sexual side effects.
✅ 99.9% prostate cancer-specific survival at the 10-year mark.

If you or a loved one has been diagnosed with localised prostate cancer, this study highlights why focal therapy should be part of the conversation.

👉 Read the full breakthrough study here: https://www.imperial.nhs.uk/about-us/news/new-study-shows-focal-therapy-treats-prostate-cancer

https://www.dailymail.com/health/article-15983725/amp/New-prostate-cancer-therapy-Jeremy-Clarkson-cuts-effects-risk.html

Ask your urologist about Sonablate HIFU today or visit Prost8 https://www.prost8.org.uk

Home

25/06/2026

🎉 Exciting news for men in Birmingham and the West Midlands!

We are delighted to announce that Sonablate® HIFU (High Intensity Focused Ultrasound) is now available for Self Pay and Insured patients at Harborne Hospital, Birmingham.

Sonablate HIFU is a minimally-invasive, radiation-free treatment for localised prostate cancer — offering precise, targeted ablation with minimal side effects and a faster return to everyday life.

✅ Real-time ultrasound guidance
✅ Bloodless, no incisions
✅ Healthy tissue sparing
✅ Repeatable if needed
✅ Minimal impact on quality of life

If you or someone you know has been diagnosed with prostate cancer and would like to explore your treatment options, get in touch with our team today or contact HCA The Harborne Hospital, Birmingham.